— Know what they know.
Not Investment Advice

BIB

ProShares Ultra Nasdaq Biotechnology
1W: -4.1% 1M: -9.9% 3M: +3.2% YTD: +37.8% 1Y: +75.2% 3Y: +131.1% 5Y: +9.4%
$109.80
-0.67 (-0.61%)
 
Weekly Expected Move ±5.7%
$97 $103 $110 $116 $122
ETF NASDAQ · AUM $88.9M
Key Statistics
AUM$89M
Holdings246
Top 10 Wt41.5%
Volume9,847
Avg Volume10,608
Beta1.20
Portfolio Fundamentals
P/E40.6
P/B7.9
Div Yield0.54%
ROE11.6%
% Profitable23%
Inception2010-04-07
Sector Allocation
Healthcare 54.5%
Other 27.9%
Financial Services 17.6%
Top 10 Holdings
# Name Ticker Weight % Market Value Shares
1 Net Other Assets (Liabilities) — 27.79% $26.9M 26,895,259
2 PROSHARES GENIUS MNY MKT ETF IQMM 17.57% $17.0M 170,000
3 GILEAD SCIENCES INC GILD 4.46% $4.3M 28,945
4 AMGEN INC AMGN 4.29% $4.2M 9,854
5 VERTEX PHARMACEUTICALS INC VRTX 4.20% $4.1M 7,779
6 MODERNA INC MRNA 2.75% $2.7M 13,843
7 REGENERON PHARMACEUTICALS REGN 2.75% $2.7M 3,507
8 REVOLUTION MEDICINES INC RVMD 1.58% $1.5M 7,432
9 ILLUMINA INC ILMN 1.48% $1.4M 5,236
10 BIOGEN INC BIIB 1.20% $1.2M 5,123

Recent Holding Changes

Date Holding Change Details
2026-10-01 IBRX Changed 35365 → 36747
2026-10-01 MBX Changed 1607 → 1670
2026-10-01 EOLS Changed 2204 → 2289
2026-10-01 TRVI Changed 4754 → 4940
2026-10-01 BEAM Changed 3447 → 3582

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms